Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Adult Spinal Muscular Atrophy (SMA) China Registry

View source ↗

Summary

Biogen-sponsored adult spinal muscular atrophy registry in China (NCT05618379) is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Biogen | Conditions: Muscular Atrophy, Spinal | Status: ACTIVE_NOT_RECRUITING